Anitha Krishnan

Company: Aviceda Therapeutics

Job title: Executive Director - Research

Seminars:

Panel Discussion Is 2024 the Year of Dry AMD?: Evaluating Current Safety, Delivery & Regulatory Challenges, Recent Successes with Approved GA Drugs & the Future of Dry AMD & GA Drug Development 9:00 am

Discussing the potential of targeting multiple pathways, such as complement and inflammasomes, with a single drug to halt disease progression Exploring the potential of combination therapies to tackle multifaceted challenges and revolutionize treatment paradigms for early, intermediate and late AMD Uncovering novel preclinical models that can recapitulate the macular microenvironment in dry AMD and GA…Read more

day: Conference Day 1

Utilizing Genomics & Proteomics Approaches to Understand Disease Pathogenesis of Dry AMD & Geographic Atrophy 1:30 pm

Revolutionizing the latest advancement in genomics and proteomics to improve understanding of disease pathogenesis, beyond simple genetic mutations Uncovering the relationships between genomic alterations and disease phenotypes, and gaining insights into how inflammation can lead to different disease manifestations Discussing emerging methodologies and technologies advancing the understanding of complex molecular interactions underlying disease progression and…Read more

day: Conference Day 1